RT @venkmurthy: @MGKatz036 @jedicath @cardiobrief Layered testing has been maligned in the past. It is absolutely helpful if you can use ch…
@MGKatz036 @jedicath @cardiobrief Layered testing has been maligned in the past. It is absolutely helpful if you can use cheap, high NPV tests with low rate of FP as pre-filter. We wrote about it here: https://t.co/oUwbqI4y00 @michaelTCTMD
@bmj_latest @khurramn1 @bnallamo @DrMarthaGulati @RogueRad @anish_koka @SVRaoMD @onco_cardiology @RonBlankstein @almallahmo @drjohnm @ADAlthousePhD Here is the cite for the figure above: https://t.co/NiE9q8It9a
@anish_koka @YairGranot @jnmafi @DavidLBrownMD @boback @ProfHayward @willsuh76 In a low prevalence population, all tests will struggle. This is a figure from a paper @khurramn1 and I wrote recently discussing the issue. https://t.co/oUwbqI4y00 https://t.c
If we are dealing with such low pre-test risk populations, very hard test can perform all that well. See editorial @khurramn1 and I wrote about this. https://t.co/NiE9q904xK https://t.co/ClCfPR7sLT
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
This link provides free access past paywall: https://t.co/lbP3QB9328
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
RT @venkmurthy: Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of…
Joint commentary with @khurramn1 on the problems with testing lower risk people and how using CAC to enrich for presence of disease may help rescue positive predictive value. Similar concepts could apply in any testing of low prevalence populations. https